Loading...

Ubiquitech Software Corp.

UBQU•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$-0.00(-99.00%)
U.S. Market opens in 60h 47m

Ubiquitech Software Corp. (UBQU) Stock Overview

Explore Ubiquitech Software Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap635.9K
P/E Ratio-3.78
EPS (TTM)N/A
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

UBQU Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ubiquitech Software Corp. (UBQU) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.78 and a market capitalization of 635.9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-80.00%
5-Day Change
1900.00%
1-Month Change
-80.00%
3-Month Change
1900.00%
6-Month Change
1900.00%
Year-to-Date (YTD) Change
-80.00%
1-Year Change
1900.00%
3-Year Change
-60.00%
5-Year Change
-97.14%
All-Time (Max) Change
-100.00%

Contact Information

https://ubiquitechsoftware.com
866-667-6765
3570 East 12th Avenue, Denver, CO, 80206

Company Facts

25 Employees
IPO DateFeb 9, 2009
CountryUS
Actively Trading

Frequently Asked Questions